home / stock / fulc / fulc message board
Subject | By | Source | When |
---|---|---|---|
znewcar1: $FULC 20% v1,358M c12.30 f52,051M H12.41 ML5.11 | znewcar1 | investorshangout | 01/10/2023 10:33:05 PM |
In some for a bounce play at $3.86 | ottoman | investorshub | 06/12/2022 5:03:11 PM |
what a great short today 25 bucks, just | NYCJR | investorshub | 08/11/2021 9:46:57 PM |
Also > The company reported $4.40 million in | crudeoil24 | investorshub | 08/10/2021 4:26:00 PM |
Way up premarket on sickle cell news. | axconth | investorshub | 08/10/2021 1:10:02 PM |
$FULC is in Phase 3 trials with a | PennyWorld | investorshub | 12/05/2020 9:47:25 PM |
News, Short Squeeze, Breakout and More Instantly...
Fulcrum Therapeutics Inc. Company Name:
FULC Stock Symbol:
NYSE Market:
? Entered into a collaboration and ex-U.S. license agreement with Sanofi for the development and commercialization of losmapimod ? ? On tra...
Aileron Therapeutics Inc. (ALRN) is expected to report for Q1 2024 DZS Inc. (DZSI) is expected to report $-0.09 for Q1 2024 Bitfarms Ltd. (BITF) is expected to report $-0.03 for Q1 2024 180 Degree Capital Corp. (TURN) is expected to report for quarter end 2024-03-31 Abacus Life In...
― Entered into a collaboration and ex-U.S. license agreement with Sanofi for the development and commercialization of losmapimod ― ― On track to report topline data for Phase 3 REACH trial of losmapimod in facioscapulohumeral muscular dystrophy (FSHD) in the fourt...